Arcutis Biotherapeutics(ARQT)
WESTLAKE VILLAGE, CABiotechnology
Focus: Arcutis is a public biotech company focused on reformulated topical dermatology products, currently generating revenue from ZORYVE (roflumilast) for dermatological indications. The company operates as a late-stage clinical-stage biotech with emerging commercial scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
20
Should You Work at Arcutis Biotherapeutics?
AI assessmentBest-fit for dermatology-focused scientists and commercial professionals willing to bet on pipeline execution; avoid if you prioritize financial stability or diversified revenue streams.
Why Work Here
- Commercial inflection point: ZORYVE revenue grew from $4M (FY2024) to $60M (FY2025), demonstrating market traction and expansion opportunity
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$60M
Key Products
Growth
Help build intelligence for Arcutis Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.